| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.60B | +8.2% |
| Cost of Revenue | $7.60B | +11.5% |
| Gross Profit | $9.00B | +5.5% |
| R&D Expense | $70.0M | +0.0% |
| SG&A Expense | $5.35B | +6.7% |
| Operating Income | $3.58B | +38.0% |
| Pre-tax Income | $2.69B | +40.4% |
| Income Tax | $608.0M | +28.5% |
| Net Income | $2.08B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.03B | +101.2% |
| Accounts Receivable | $1.67B | +11.3% |
| Inventory | $1.73B | +33.4% |
| Current Assets | $5.27B | +31.7% |
| Total Assets | $55.46B | +3.8% |
| Current Liabilities | $8.29B | +2.5% |
| Long-term Debt | $13.04B | +1.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.99B | -10.3% |
| Capital Expenditures | $486.0M | -13.7% |
| Investing Cash Flow | -$573.0M | +64.5% |
| Financing Cash Flow | -$999.0M | -348.0% |
| Free Cash Flow | $1.50B | -9.1% |
| +44.3% |
| EPS (Basic) | $1.53 | +44.3% |
| EPS (Diluted) | $1.53 | +45.7% |
| Total Liabilities |
| $29.94B |
| +2.6% |
| Stockholders' Equity | $25.52B | +5.3% |